FLIXONASE Side Effects

6919363-8 | Ageusia, Anosmia
on Aug 04, 2010 Female patient from BRAZIL , weighting 145.5 lb, was diagnosed with rhinitis and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia. Flixonase dosage: 4puff Twice Per Day.

6844226-6 | Angina Pectoris
Patient was taking Flixonase (View Usage). Patient had the following side effects: angina pectoris on Jul 06, 2010 from RUSSIAN FEDERATION Additional patient health information: Male patient , 36 years of age, . Flixonase dosage: 400mg Per Day.

6751704-7 | Hyperhidrosis
Adverse event was reported on May 20, 2010 by a Female patient taking Flixonase (View Usage) (Dosage: 5ml Per Day) . Location: CHINA , child 2 years of age, After Flixonase was administered, patient had the following side effects: hyperhidrosis.

6749657-0 | Feeling Hot
on May 24, 2010 Male patient from UNITED KINGDOM , 78 years of age, weighting 168.0 lb, was diagnosed with nasal congestion and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: feeling hot. Flixonase dosage: 2iuax Per Day.


6685092-1 | Dry Eye, Eye Disorder, Eye Movement Disorder, Pain, Pharyngeal Disorder, Tonsillar Ulcer, Vision Blurred, Visual Acuity Reduced
on Apr 10, 2010 Female patient from UNITED KINGDOM , 57 years of age, was treated with Flixonase (View Usage). Patient had the following side effects: dry eye, eye disorder, eye movement disorder, pain (What is pain?), pharyngeal disorder, tonsillar ulcer, vision blurred, visual acuity reduced. Flixonase dosage: 2puff Per Day.

6604892-7 | Apnoea, Disorientation, Dyspnoea, Epistaxis, Eye Pain, Eye Rolling, Foreign Body, Haemoptysis, Lividity
Patient was taking Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: apnoea, disorientation, dyspnoea, epistaxis, eye pain, eye rolling, foreign body, haemoptysis, lividity on Feb 19, 2010 from POLAND Additional patient health information: Female patient , weighting 33.07 lb, was diagnosed with rhinitis and. Flixonase dosage: . During the same period patient was treated with NUROFEN (View Nurofen Review and Nurofen Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ).

6135521-7 | Epistaxis, Eye Haemorrhage
Adverse event was reported on Mar 20, 2009 by a Female patient taking Flixonase (View Usage) (Dosage: 2spr Per Day) . Location: UNITED KINGDOM , 15 years of age, Patient experienced the following unwanted or unexpected effects: epistaxis, eye haemorrhage.

6115076-3 | Lacrimation Increased, Swelling Face
on Mar 05, 2009 Female patient from UNITED KINGDOM , 60 years of age, weighting 207.2 lb, was treated with Flixonase (View Usage). Patient had the following side effects: lacrimation increased, swelling face. Flixonase dosage: 12 Per Day. During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ), MONTELUKAST (View Montelukast Review and Montelukast Label ), LORATADINE (View Loratadine Review and Loratadine Label ), EPADERM (View Epaderm Review and Epaderm Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), MEBEVERINE HYDROCHLORIDE (View Mebeverine Hydrochloride Review and Mebeverine Hydrochloride Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ).

6011009-9 | Mucosal Haemorrhage, Nasal Discomfort, Nasal Dryness, Scab, Skin Lesion
on Dec 16, 2008 Female patient from RUSSIAN FEDERATION , 25 years of age, weighting 121.3 lb, was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: mucosal haemorrhage, nasal discomfort, nasal dryness, scab (What is scab?), skin lesion. Flixonase dosage: 100mg Per Day.

5819165-X | Dizziness, Headache, Hypertensive Crisis
Patient was taking Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), headache (What is headache?), hypertensive crisis on Jul 17, 2008 from BRAZIL Additional patient health information: Male patient , 16 years of age, was diagnosed with sinusitis (What is sinusitis?) and. Flixonase dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

5817308-5 | Brain Abscess
Adverse event was reported on Jul 15, 2008 by a Male patient taking Flixonase (View Usage) (Dosage: ) . Location: NETHERLANDS , 37 years of age, Patient had the following side effects: brain abscess. During the same period patient was treated with NASONEX (50mcg Twice Per Day) (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

5801728-9 | Epistaxis, Retinal Vein Thrombosis
on Jun 30, 2008 Female patient from NETHERLANDS , 74 years of age, weighting 165.3 lb, was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: epistaxis, retinal vein thrombosis. Flixonase dosage: 1drop Twice Per Day. During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ).

5773929-X | Abortion Missed
on Jun 06, 2008 Female patient from DENMARK , 31 years of age, weighting 141.1 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: abortion missed. Flixonase dosage: .

5762548-7 | Dizziness, Gait Disturbance, Monoparesis, Monoplegia, Nausea
Patient was taking Flixonase (View Usage). Patient had the following side effects: dizziness (What is dizziness?), gait disturbance, monoparesis, monoplegia, nausea (What is nausea?) on May 27, 2008 from NETHERLANDS Additional patient health information: Male patient , 68 years of age, . Flixonase dosage: 400ug Twice Per Day. During the same period patient was treated with CELESTON (View Celeston Review and Celeston Label ).

5746474-5 | Epistaxis
Adverse event was reported on May 19, 2008 by a Male patient taking Flixonase (View Usage) (Dosage: ) was diagnosed with rhinorrhoea, cardiac disorder and. Location: DENMARK , 63 years of age, After Flixonase was administered, patient had the following side effects: epistaxis. During the same period patient was treated with MAGNYL (100mg Per Day) (View Magnyl Review and Magnyl Label ), ATACAND (32mg Per Day) (View Atacand Review and Atacand Label ), SIMVASTATIN (40mg Per Day) (View Simvastatin Review and Simvastatin Label ), DIMITONE (25mg Per Day) (View Dimitone Review and Dimitone Label ). Patient was hospitalized.

5670902-7 | Asphyxia, Hypertension
on Mar 14, 2008 Male patient from BRAZIL , 38 years of age, weighting 176.4 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, hypertension. Flixonase dosage: 55mcg Twice Per Day.

5500827-9 | Epistaxis
on Oct 19, 2007 Female patient from IRELAND , 49 years of age, was treated with Flixonase (View Usage). Patient had the following side effects: epistaxis. Flixonase dosage: . During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

5469530-8 | Accidental Exposure, Crying, Traumatic Shock
Patient was taking Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: accidental exposure, crying, traumatic shock on Sep 25, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 13 years of age, . Flixonase dosage: .

5464295-8 | Accidental Exposure, Crying, Traumatic Shock
Adverse event was reported on Sep 14, 2007 by a Female patient taking Flixonase (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 13 years of age, Patient experienced the following unwanted or unexpected effects: accidental exposure, crying, traumatic shock.

5407259-2 | Deafness, Deafness Unilateral
on Jul 27, 2007 Male patient from UNITED KINGDOM , 73 years of age, was treated with Flixonase (View Usage). Patient had the following side effects: deafness, deafness unilateral. Flixonase dosage: . Patient was hospitalized.

5396642-X | Atrial Fibrillation, Overdose
on Jul 20, 2007 Male patient from BRAZIL , 51 years of age, weighting 145.5 lb, was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), overdose. Flixonase dosage: 3spr Per Day. During the same period patient was treated with PRELONE (View Prelone Review and Prelone Label ). Patient was hospitalized.

5390119-3 | Pruritus, Swollen Tongue
Patient was taking Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, swollen tongue on Jul 09, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, weighting 154.3 lb, . Flixonase dosage: . During the same period patient was treated with AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), CO PROXAMOL (View Co-proxamol Review and Co-proxamol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ).

5387751-X | Angioedema, Erythema, Face Oedema, Joint Swelling, Oedema Peripheral, Pruritus, Urticaria
Adverse event was reported on Jul 06, 2007 by a Female patient taking Flixonase (View Usage) (Dosage: ) was diagnosed with sinusitis (What is sinusitis?) and. Location: CROATIA (local name: Hrvatska) , 46 years of age, Patient had the following side effects: angioedema, erythema, face oedema, joint swelling, oedema peripheral, pruritus, urticaria. During the same period patient was treated with KLIMICIN (300mg Twice Per Day) (View Klimicin Review and Klimicin Label ), LORATADINE (5mg Per Day) (View Loratadine Review and Loratadine Label ).

5337277-4 | Deafness
on May 22, 2007 Male patient from NETHERLANDS , 53 years of age, weighting 176.4 lb, was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: deafness. Flixonase dosage: . During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), NASONEX (50ug Per Day) (View Nasonex Review and Nasonex Label ), PREDNISOLONE (30mg Per Day) (View Prednisolone Review and Prednisolone Label ), CELESTONE (.5mg Per Day) (View Celestone Review and Celestone Label ), XYZAL (5mg Per Day) (View Xyzal Review and Xyzal Label ), SINGULAIR (10mg Per Day) (View Singulair Review and Singulair Label ).

5337240-3 | Chest Pain, Dyspnoea
on May 25, 2007 Female patient from BRAZIL , 54 years of age, was diagnosed with asthma (What is asthma?) and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea. Flixonase dosage: . During the same period patient was treated with SEREVENT (View Serevent Review and Serevent Label ), DIOVAN (View Diovan Review and Diovan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5284543-7 | Labyrinthitis, Tinnitus
Patient was taking Flixonase (View Usage). Patient had the following side effects: labyrinthitis, tinnitus (What is tinnitus?) on Mar 26, 2007 from SOUTH AFRICA Additional patient health information: Male patient , 47 years of age, weighting 180.8 lb, . Flixonase dosage: . During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), ACC 200 (View Acc 200 Review and Acc 200 Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), MEDROL (View Medrol Review and Medrol Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ).

5278619-8 | Breech Delivery
Adverse event was reported on Mar 21, 2007 by a Female patient taking Flixonase (View Usage) (Dosage: 50mcg Four Times Per Day) was diagnosed with nasal mucosal disorder and. Location: NETHERLANDS , 31 years of age, weighting 163.1 lb, After Flixonase was administered, patient had the following side effects: breech delivery. Patient was hospitalized.

5256486-6 | Blood Pressure Decreased, Hypersensitivity, Shock
on Feb 27, 2007 Male patient from NETHERLANDS , 61 years of age, weighting 194.0 lb, was diagnosed with rhinitis allergic and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, hypersensitivity, shock. Flixonase dosage: 50mcg Twice Per Day. During the same period patient was treated with ASCAL (100mg Per Day) (View Ascal Review and Ascal Label ), METFORMIN HCL (1000mg Per Day) (View Metformin Hcl Review and Metformin Hcl Label ), LIPITOR (20mg Per Day) (View Lipitor Review and Lipitor Label ), ENALAPRIL MALEATE (5mg Per Day) (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

5230558-4 | Angioedema, Hypersensitivity, Loss Of Consciousness
on Jan 29, 2007 Male patient from NETHERLANDS , 61 years of age, was diagnosed with rhinitis allergic and was treated with Flixonase (View Usage). Patient had the following side effects: angioedema, hypersensitivity, loss of consciousness. Flixonase dosage: 100mcg Per Day. During the same period patient was treated with ENALAPRIL MALEATE (5mg Per Day) (View Enalapril Maleate Review and Enalapril Maleate Label ), ASCAL CARDIO (100mg Per Day) (View Ascal Cardio Review and Ascal Cardio Label ), METFORMIN HCL (1000mg Per Day) (View Metformin Hcl Review and Metformin Hcl Label ), LIPITOR (20mg Per Day) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5165589-6 | Chronic Sinusitis
Patient was taking Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: chronic sinusitis on Nov 28, 2006 from RUSSIAN FEDERATION Additional patient health information: Female patient , 13 years of age, weighting 121.3 lb, was diagnosed with seasonal allergy and. Flixonase dosage: . During the same period patient was treated with LORATADINE (10mg Per Day) (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

5164766-8 | Nasal Dryness, Oedema Mucosal
Adverse event was reported on Nov 28, 2006 by a Male patient taking Flixonase (View Usage) (Dosage: ) was diagnosed with seasonal allergy and. Location: RUSSIAN FEDERATION , 45 years of age, weighting 207.2 lb, Patient experienced the following unwanted or unexpected effects: nasal dryness, oedema mucosal. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), LORATADINE (10mg Per Day) (View Loratadine Review and Loratadine Label ).

5152158-7 | Euphoric Mood, Tremor
on Nov 14, 2006 Female patient from ARGENTINA , 15 years of age, was diagnosed with rhinitis allergic and was treated with Flixonase (View Usage). Patient had the following side effects: euphoric mood, tremor. Flixonase dosage: 100mcg Per Day. During the same period patient was treated with FRENALER (View Frenaler Review and Frenaler Label ). Patient was hospitalized.

5117762-0 | Epistaxis, Nasal Discomfort, Nasal Disorder, Sneezing, Wound
on Sep 22, 2006 Female patient from MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF , 30 years of age, was diagnosed with rhinitis allergic and was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: epistaxis, nasal discomfort, nasal disorder, sneezing, wound (What is wound?). Flixonase dosage: 50mcg Per Day. During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

5087550-2 | Fall
Patient was taking Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?) on Aug 21, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 65 years of age, weighting 140.0 lb, was diagnosed with chronic sinusitis and. Flixonase dosage: . During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), THYROXIN (View Thyroxin Review and Thyroxin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5022298-1 | Anaphylactic Shock, Nausea, Syncope
Adverse event was reported on May 30, 2006 by a Female patient taking Flixonase (View Usage) (Dosage: ) . Location: CZECH REPUBLIC , 29 years of age, Patient had the following side effects: anaphylactic shock, nausea (What is nausea?), syncope. During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), LORATADINE AND PSEUDOEPHEDRINE SULFATE (View Loratadine And Pseudoephedrine Sulfate Review and Loratadine And Pseudoephedrine Sulfate Label ). Patient was hospitalized.

5005308-7 | Dysmenorrhoea
on May 11, 2006 Female patient from RUSSIAN FEDERATION , 23 years of age, weighting 121.3 lb, was diagnosed with contraception and was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: dysmenorrhoea. Flixonase dosage: . During the same period patient was treated with ETHINYLOESTRADIOL + DIENOGEST (View Ethinyloestradiol + Dienogest Review and Ethinyloestradiol + Dienogest Label ).

4986366-2 | Vision Blurred, Visual Acuity Reduced, Visual Disturbance
on Mar 01, 2006 Male patient from UNITED KINGDOM , 81 years of age, was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: vision blurred, visual acuity reduced, visual disturbance. Flixonase dosage: . During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ).

4972973-X | Cataract, Cataract Operation
Patient was taking Flixonase (View Usage). Patient had the following side effects: cataract (What is cataract?), cataract operation on Apr 05, 2006 from BRAZIL Additional patient health information: Female patient , 70 years of age, was diagnosed with rhinitis and. Flixonase dosage: .

4938314-9 | Visual Acuity Reduced, Visual Disturbance
Adverse event was reported on Mar 01, 2006 by a Male patient taking Flixonase (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 81 years of age, After Flixonase was administered, patient had the following side effects: visual acuity reduced, visual disturbance. During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ).

4896537-1 | Epistaxis, Nasal Mucosa Atrophy
on Jan 24, 2006 Female patient from RUSSIAN FEDERATION , 20 years of age, was diagnosed with rhinitis perennial and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, nasal mucosa atrophy. Flixonase dosage: .

4892341-9 | Deafness
on Jan 19, 2006 Male patient from BRAZIL , 14 years of age, weighting 50.71 lb, was diagnosed with adenoidal hypertrophy and was treated with Flixonase (View Usage). Patient had the following side effects: deafness. Flixonase dosage: .

4863822-9 | Epistaxis
Patient was taking Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: epistaxis on Sep 26, 2005 from UNITED STATES Additional patient health information: Male patient , 45 years of age, . Flixonase dosage: . During the same period patient was treated with FLUTICASONE PROPIONATE (2spr Per Day) (View Fluticasone Propionate Review and Fluticasone Propionate Label ).

4772778-9 | Anaphylactic Reaction, Face Oedema, Heart Rate Increased, Hypersensitivity, Muscle Rigidity, Musculoskeletal Stiffness, Pharyngeal Oedema, Suffocation Feeling, Swollen Tongue
Adverse event was reported on Aug 25, 2005 by a Female patient taking Flixonase (View Usage) (Dosage: ) was diagnosed with chronic sinusitis and. Location: BELGIUM , 23 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, face oedema, heart rate increased, hypersensitivity, muscle rigidity, musculoskeletal stiffness, pharyngeal oedema, suffocation feeling, swollen tongue. During the same period patient was treated with MERCILON (View Mercilon Review and Mercilon Label ). Patient was hospitalized and became disabled.

4768718-9 | Depression, Dry Mouth, Hypertension, Nasal Congestion, Nasal Septum Deviation, Neoplasm Malignant, Pain, Palatal Disorder, Pharyngitis
on Sep 05, 2005 Female patient from BRAZIL , 62 years of age, weighting 198.4 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Flixonase (View Usage). Patient had the following side effects: depression (What is depression?), dry mouth, hypertension, nasal congestion, nasal septum deviation, neoplasm malignant, pain (What is pain?), palatal disorder, pharyngitis. Flixonase dosage: 50mcg Per Day. During the same period patient was treated with PROPRANOLOL (2tab Three Times Per Day) (View Propranolol Review and Propranolol Label ).

4764631-1 | Choking
on Sep 01, 2005 Male patient from BRAZIL , child 1 years of age, weighting 22.05 lb, was diagnosed with rhinitis and was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: choking (What is choking?). Flixonase dosage: 50mcg Single Dose.

4716009-4 | Lymphadenitis
Patient was taking Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: lymphadenitis on Jul 07, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 46 years of age, weighting 191.8 lb, was diagnosed with seasonal allergy and. Flixonase dosage: .

4705410-0 | Coarctation Of The Aorta, Gastrointestinal Malformation, Heart Disease Congenital, Oesophageal Atresia, Salivary Hypersecretion, Ventricular Septal Defect
Adverse event was reported on Nov 25, 2004 by a Male patient taking Flixonase (View Usage) (Dosage: 1unit Per Day) was diagnosed with asthma (What is asthma?) and. Location: FRANCE , weighting 6.39 lb, Patient had the following side effects: coarctation of the aorta, gastrointestinal malformation, heart disease congenital, oesophageal atresia, salivary hypersecretion, ventricular septal defect. During the same period patient was treated with BRONCHODUAL (1unit Three Times Per Day) (View Bronchodual Review and Bronchodual Label ), TELFAST (View Telfast Review and Telfast Label ), AERIUS (View Aerius Review and Aerius Label ), ZADITEN (1unit Per Day) (View Zaditen Review and Zaditen Label ), SERETIDE (1puff Twice Per Day) (View Seretide Review and Seretide Label ), CONTRACEPTIVE PILL (View Contraceptive Pill Review and Contraceptive Pill Label ). Patient was hospitalized.

4699305-9 | Coarctation Of The Aorta, Gastrointestinal Malformation, Heart Disease Congenital, Neonatal Disorder, Oesophageal Atresia, Salivary Hypersecretion, Ventricular Septal Defect
on Nov 25, 2004 Male patient from , weighting 6.39 lb, was diagnosed with asthma (What is asthma?) and was treated with Flixonase (View Usage). After Flixonase was administered, patient had the following side effects: coarctation of the aorta, gastrointestinal malformation, heart disease congenital, neonatal disorder, oesophageal atresia, salivary hypersecretion, ventricular septal defect. Flixonase dosage: 1unit Per Day. During the same period patient was treated with BRONCHODUAL (1unit Three Times Per Day) (View Bronchodual Review and Bronchodual Label ), TELFAST (View Telfast Review and Telfast Label ), AERIUS (View Aerius Review and Aerius Label ), ZADITEN (1unit Per Day) (View Zaditen Review and Zaditen Label ), SERETIDE (1puff Twice Per Day) (View Seretide Review and Seretide Label ), CONTRACEPTIVE PILL (View Contraceptive Pill Review and Contraceptive Pill Label ). Patient was hospitalized.

4589794-2 | Anosmia, Condition Aggravated, Deafness, Mucosal Inflammation, Otitis Media, Otosalpingitis, Rhinitis
on Oct 27, 2004 Female patient from , 62 years of age, weighting 123.5 lb, was diagnosed with rhinitis and was treated with Flixonase (View Usage). Patient experienced the following unwanted or unexpected effects: anosmia, condition aggravated, deafness, mucosal inflammation, otitis media, otosalpingitis, rhinitis. Flixonase dosage: .

4561638-4 | Anxiety, Claustrophobia, Psychomotor Hyperactivity
Patient was taking Flixonase (View Usage). Patient had the following side effects: anxiety (What is anxiety?), claustrophobia, psychomotor hyperactivity on Jan 20, 2005 from Additional patient health information: Male patient , 59 years of age, weighting 165.3 lb, was diagnosed with nasal polyps, psoriasis and. Flixonase dosage: 6drop Per Day. During the same period patient was treated with CALCIPOTRIOL (View Calcipotriol Review and Calcipotriol Label ).